decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
seed logo
FAQs NIH Staff Contact & Help

Avanti Biosciences

Avanti Biosciences Inc. is a preclinical-stage biopharmaceutical company based in the JLAB in San Diego. It specializes in discovering and developing novel small-molecule compounds for treating neurodegenerative disorders like Alzheimer’s disease (AD) and fibrotic disorders such as Idiopathic Pulmonary Fibrosis (IPF) and Liver Fibrosis. Its lead molecule, ABI-171, has demonstrated significant antifibrotic activity, showing promising results in both the STAM mouse model for liver fibrosis and the Bleomycin mouse model for IPF. 

The company's vision is to become a global leader in developing innovative therapies for unmet medical needs in neurodegenerative and fibrotic diseases. Leveraging its expertise in small-molecule drug discovery and its robust pipeline, the company aims to deliver breakthrough treatments that improve patient outcomes and quality of life
Contact Name:
Gian Luca Araldi
Contact Email:
[email protected]
Website: https://www.avantibiosciences.com/
City, State – Congressional District: San Diego,
CA
–
50
Technology: Drug
Funding: Aging (NIA), Diabetes, Digestive, and Kidney (NIDDK)
NIH Projects: NIH RePorter for Avanti Biosciences
Sponsored Event(s): Life Sciences Summit | 2024
National Institutes of Health
Bethesda, MD 20892

Stay in the Loop

Subscribe to our mailing list for updates on deadlines and important information.

Site Map

Fraud, Waste and Abuse

HHS Vulnerability Disclosure | Technical Issues: E-mail OER Webmaster